Cargando…
Chromosome microarray analysis combined with karyotype analysis is a powerful tool for the detection in pregnant women with high-risk indicators
BACKGROUND: Karyotype analysis and fluorescence in situ hybridization (FISH) are commonly used for prenatal diagnosis, however they have many disadvantages. Chromosome microarray analysis (CMA) has the potential to overcome these disadvantages. This study aimed to evaluate the clinical value of CMA...
Autores principales: | Qian, Guanhua, Cai, Liuyun, Yao, Hong, Dong, Xiaojing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638706/ https://www.ncbi.nlm.nih.gov/pubmed/37951870 http://dx.doi.org/10.1186/s12884-023-06052-z |
Ejemplares similares
-
Chromosomal mosaicism detected by karyotyping and chromosomal microarray analysis in prenatal diagnosis
por: Zhang, Yi, et al.
Publicado: (2020) -
Chromosomal Microarray Analysis for the Fetuses with Aortic Arch Abnormalities and Normal Karyotype
por: Wu, Xiaoqing, et al.
Publicado: (2020) -
Chromosomal microarray analysis vs. karyotyping for fetal ventriculomegaly: a meta-analysis
por: Sun, Yan, et al.
Publicado: (2022) -
Chromosomal Microarray Analysis versus Karyotyping in Fetuses with Increased Nuchal Translucency
por: Cicatiello, Rita, et al.
Publicado: (2019) -
The difference between karyotype analysis and chromosome microarray for mosaicism of aneuploid chromosomes in prenatal diagnosis
por: Hao, MengZhe, et al.
Publicado: (2020)